Drug-resistant tuberculosis: Difference between revisions
From IDWiki
m (Aidan moved page Mycobacterium tuberculosis Multi-drug-resistant tuberculosis (MDR-TB) to Multi-drug-resistant tuberculosis without leaving a redirect) |
No edit summary |
||
Line 1: | Line 1: | ||
⚫ | |||
− | = Multi-drug-resistant tuberculosis (MDR-TB) = |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
− | |||
⚫ | |||
* 8 months of an intensive four-drug regimen that includes any four drugs to which it is susceptible, in order of preference: |
* 8 months of an intensive four-drug regimen that includes any four drugs to which it is susceptible, in order of preference: |
||
Line 13: | Line 11: | ||
** Other second-line agents, starting with ethionamide |
** Other second-line agents, starting with ethionamide |
||
* Followed by 12 months of a less intensive regimen (at least three effective drugs), for a total of at least 20 months |
* Followed by 12 months of a less intensive regimen (at least three effective drugs), for a total of at least 20 months |
||
+ | |||
+ | [[Category:TB]] |
Revision as of 23:24, 14 August 2019
Definition
- Tuberculosis infection that is resistant to both first-line drugs, isoniazid and rifampin
Management
- 8 months of an intensive four-drug regimen that includes any four drugs to which it is susceptible, in order of preference:
- Any first-line agents to which it is still susceptible
- A fluoroquinolone (except ciprofloxacin)
- An injectable: kanamycin, or other parenteral agent
- Other second-line agents, starting with ethionamide
- Followed by 12 months of a less intensive regimen (at least three effective drugs), for a total of at least 20 months